Saul del Angel Pacheco Morales Gives Historical Review on Erythropoietin
Saul del Angel Pacheco Morales, Medical Advisor Oncology And High Specialty at Synthon México, shared on LinkedIn:
”ERYTHROPOIETIN
Erythropoietin (EPO): the treatment that changed anemia in kidney disease
For many years, people with chronic kidney disease suffered from severe anemia, extreme fatigue, and dependence on blood transfusions.
Today, this is very different, thanks to erythropoietin (EPO).
This image shows how this treatment came about:
1906 – Doctors discover that the body produces a substance that stimulates the formation of red blood cells. They exposed the serum of anemic animals to other animals and noticed an increase in red cell production.
1953–1957 – It is confirmed that the kidney is the organ that produces this substance (EPO).
1977 – Human erythropoietin is isolated for the first time.
1985 – Scientists learn how to produce EPO in the laboratory (recombinant erythropoietin).
1986–1987 – The first dialysis patients show increased hemoglobin levels and fewer transfusions.
1989 – The FDA approves EPO for treating anemia in kidney disease.
Thanks to EPO, millions of patients have been able to:
- Reduce or avoid transfusions
- Improve their quality of life
This is one of the great success stories of modern medicine and nephrology.”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion
-
Apr 22, 2026, 16:29CBTH 2026 Opens with First Workshop in Germany – European Hematology Association
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL